Breakthrough in Acute Myeloid Leukemia Diagnosis: Researchers Develop Novel Fluorescent Sensing Material
Researchers at the State Key Laboratory have made a significant contribution to the field of oncology by developing a novel fluorescent sensing material, N/CDs@Eu-MOF, to detect biomarkers associated with childhood obesity and acute myeloid leukemia (AML). This innovative approach enables the sensitive and non-invasive measurement of biomarkers, such as glycine and L-lysine, in living cells, potentially leading to early diagnosis and treatment of AML.
Key Takeaways:
- The novel fluorescent sensing material, N/CDs@Eu-MOF, is capable of detecting biomarkers associated with childhood obesity and AML, with detection limits of 0.86 mM for glycine and 0.12 mM for L-lysine.
- The material can distinguish between the enantiomers of L-lysine, which is essential for precise diagnosis and treatment.
- The N/CDs@Eu-MOF composite was applied in ratiometric fluorescence imaging of glycine and L-lysine levels in living cells, demonstrating its potential as a sensitive and non-invasive tool.
- This study provides a novel approach for the quantitative evaluation of lysine levels and chiral identification of lysine enantiomers.
- The research highlights the importance of sensitive detection of biomarkers in the early diagnosis and clinical evaluation of AML-M2 disease.
- Additional authors contributing to this research include Liping Peng, Henglong Ren, Borong Ren, Mingyue Wang, Xiuli Niu, Hao Guo, and Wu Yang.
Statistics:
- Detection limits:
+ Glycine: 0.86 mM
+ L-lysine: 0.12 mM
- Enantiomer recognition: The N/CDs@Eu-MOF composite efficiently distinguishes between L-lyysine and D-lyysine.
- Fluorescence enhancement: L-lysine induces a substantial enhancement of the N/CDs characteristic peak, while D-lysine exhibits minimal impact on the fluorescence emission.
Sources:
- Analytica Chimica Acta
- Elsevier
- State Key Laboratory of Chemistry and Utilization of Carbon Based Energy Resources
- College of Chemistry Xinjiang University
- People's Republic of China